Dr. Mohamad Allaf is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute and Urologist-in-Chief of the Johns Hopkins Hospital. Dr. Allaf is a world renowned surgeon-scientist having performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. As one of the busiest robotic radical prostatectomy surgeons in the world, he aims to achieve the best outcomes for his patients. Having trained with Dr. Patrick Walsh, Dr. Allaf has used Dr. Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fund raising for research and education, and believes in expanding our base of support in order to advance our important mission. Dr. Allaf is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Renal Oncocytoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Mark Ball is a Plastic Surgeon and a Urologist in Bethesda, Maryland. Dr. Ball is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Von Hippel-Lindau (VHL) Syndrome, Renal Cell Carcinoma (RCC), Renal Oncocytoma, Nephrectomy, and Prostatectomy.

Michael Gorin is a Urologist in Cumberland, MD. Dr. Gorin is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Oncocytoma, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

Head and neck surgeon David Eisele specializes in surgery for malignant and benign tumors of the head and neck, with a focus on salivary gland neoplasms and disorders of the salivary glands that can be treated surgically. He is an expert in minimally invasive surgical approaches, including sialendoscopy. Salivary gland neoplasms and disorders are also the focus of Dr. Eisele’s research. He has published more than 300 research papers and edited multiple books related to head and neck surgery. Dr. Eisele earned a medical degree from Cornell University Medical College and completed residency training in general surgery and in otolaryngology–head and neck surgery at the University of Washington. From 2012 to 2025, he served as director of the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Eisele is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Salivary Duct Stones, Salivary Gland Tumors, Throat Cancer, Laryngectomy, and Gastrostomy.

Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Laryngectomy, and Gastrostomy.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

David Litman is an Otolaryngologist in Cumberland, Maryland. Dr. Litman is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Thyroid Nodule, Gastrostomy, and Thyroidectomy. Dr. Litman is currently accepting new patients.

Jason Riley is a Urologist in Cumberland, Maryland. Dr. Riley is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are UPJ Obstruction, Perirenal Abscess, Boils, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Riley is currently accepting new patients.

Angela Stonebraker is an Otolaryngologist in Hagerstown, Maryland. Dr. Stonebraker is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Otitis, Jones Syndrome, Ruptured Eardrum, and Infant Hearing Loss. Dr. Stonebraker is currently accepting new patients.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy.

Yemeng Lu is an Otolaryngologist in Columbia, Maryland. Dr. Lu is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Arteriovenous Malformation, Ozena, Nonallergic Rhinopathy, and Palatal Myoclonus.

Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. Dr. Pavlovich is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

Dr. Hamburger received his medical degree cum laude from the University Of Maryland School Of Medicine. He trained in internal medicine at the University of Rochester before his general surgery internship at the University of Maryland, where he also completed his Otolaryngology – Head and Neck Surgery residency and was an assistant clinical professor in the Department of Otolaryngology from 1999–2007. Dr. Hamburger is a member of the American Academy of Otolaryngology – Head and Neck Surgery. He is currently the Chairman of the Division of Otolaryngology at Johns Hopkins Howard County Medical Center. Dr. Hamburger specializes in medical and surgical care of pediatric and adult ear, nose, and throat disorders including sinusitis, voice disorders and sleep apnea. He also has a special interest in the treatment of head and neck neoplasms including cancer and thyroid nodules. When not caring for patients, Dr. Hamburger enjoys skiing, working out, photography, playing video games, and spending time with his family. Dr. Hamburger is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Trachoma, Jones Syndrome, DFNB1, and Infant Hearing Loss.

Dr. Pacheco is a graduate of the University Of Miami School Of Medicine in Florida and the University of Vermont. He completed his general surgery internship, Otolaryngology residency and clinical research rotation at the University of Miami. Dr. Pacheco is a member of the American Academy of Facial Plastics and Reconstructive Surgery. When not caring for patients, Dr. Pacheco enjoys spending time with his family, traveling, and playing racquetball. Dr. Pacheco is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), DFNB1, and Infant Hearing Loss.

Mark Schneyer is an Otolaryngologist in Owings Mills, Maryland. Dr. Schneyer is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Hearing Loss.

Ahmed Ghazi is an associate professor of urology at the Johns Hopkins University School of Medicine. He is the Director of Surgical Simulation Training and the Division of Minimally Invasive and Robotic Surgery within the Johns Hopkins Brady Urological Institute. Dr. Ghazi specializes in urologic surgical oncology using the latest techniques of minimally invasive surgery for prostate, kidney, bladder, ureteral and other genitourinary organ cancers. He also as specializes in minimal invasive treatment of complex stones of the urinary tract. Dr. Ghazi is a pioneer in the field of patient-specific surgical simulation, which has applications for training future surgeons as well as improving outcomes for patients through individualized modeling. When planning for a complex surgery, Dr. Ghazi constructs 3D models of the patient’s anatomy in order to plan and rehearse surgery prior to the actual surgery. These models span from digital renderings to tangible models used to practice the critical components of your surgery. Dr. Ghazi received his medical degree from Cairo University in Egypt in 2000, where he also completed his surgery training and urology residency. From there, Dr. Ghazi completed a laparoscopic fellowship in Paris, France in 2008, followed by a second laparoscopic fellowship in Austria in 2009. While practicing in Europe, Dr. Ghazi was accepted to the European Board of Urology. Dr. Ghazi continued his training at the University of Rochester, New York through a two-year fellowship in the robotic treatment of various urologic cancers. He then joined the staff at the urology department of University of Rochester in 2012 where he continued to practice until joining Johns Hopkins Medicine. Dr. Ghazi believes in a reciprocal relationship between innovation, surgery & research where each informs and strengthens the others. He strives to adopt innovative surgical technologies that are evidence-based, benefit his patients and translate directly to improved patient outcomes. Dr. Ghazi is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Prostate Cancer, Kidney Stones, Boils, Prostatectomy, and Nephrectomy.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

I am medical oncologist dedicated to the care of patients with genitourinary malignancies. My clinical and research focus is on the management of renal cell carcinoma (RCC). I have completed Medical Oncology Higher Specialist Training with Royal College of Physicians in Ireland and subsequently completed Advanced Medical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center in New York. Dr. Ged is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, Nephrectomy, and Thrombectomy.

Kelly Lafaro, MD, MPH, is a general surgeon with a specialty in gastrointestinal surgical oncology and hepatobiliary surgery. She is part of the Johns Hopkins Kimmel Cancer Center. Dr. Lafaro earned her medical degree from Tulane University School of Medicine and completed her residency at New York-Presbyterian/Columbia University Irving Medical Center. Her fellowship in complex general surgical oncology was completed at City of Hope National Medical Center. Dr. Lafaro’s expertise includes pancreatic adenocarcinoma, neuroendocrine tumors, minimally invasive pancreatic and liver surgeries, and colorectal liver metastases. In addition to her clinical experience, Dr. Lafaro is published in the field of liver and pancreatic cancer. She is interested in the improvement of surgical and post-surgical outcomes. Dr. Lafaro is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.